The NHS has approved three new drugs for use across Scotland, as reported by the BBC
NHS Scotland has approved the use of new medicines for migraines, psoriasis and liver cancer.
Erenumab will now be available for chronic migraines, Lenvatinib for liver cancer and Certolizumab for psoriasis.
The former will be used when at least three other preventative measures have failed.
Lenvatinib is for patients unable to undergo surgery or have a transplant.
Certolizumab will be given to moderate to severe psoriasis sufferers who haven’t responded to mainstream therapies.
The Scottish Medicines Consortium (SMC) has licensed the three drugs for use within the country.
SMC chair, Dr Alan MacDonald, said the committee hopes that the move would be welcomed by patients.